Correlation Between Central Proteina and Bakrieland Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Central Proteina and Bakrieland Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Central Proteina and Bakrieland Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Central Proteina Prima and Bakrieland Development Tbk, you can compare the effects of market volatilities on Central Proteina and Bakrieland Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Central Proteina with a short position of Bakrieland Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Central Proteina and Bakrieland Development.

Diversification Opportunities for Central Proteina and Bakrieland Development

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Central and Bakrieland is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Central Proteina Prima and Bakrieland Development Tbk in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bakrieland Development and Central Proteina is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Central Proteina Prima are associated (or correlated) with Bakrieland Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bakrieland Development has no effect on the direction of Central Proteina i.e., Central Proteina and Bakrieland Development go up and down completely randomly.

Pair Corralation between Central Proteina and Bakrieland Development

Assuming the 90 days trading horizon Central Proteina Prima is expected to generate 0.53 times more return on investment than Bakrieland Development. However, Central Proteina Prima is 1.89 times less risky than Bakrieland Development. It trades about 0.0 of its potential returns per unit of risk. Bakrieland Development Tbk is currently generating about -0.05 per unit of risk. If you would invest  5,400  in Central Proteina Prima on October 7, 2024 and sell it today you would lose (400.00) from holding Central Proteina Prima or give up 7.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Central Proteina Prima  vs.  Bakrieland Development Tbk

 Performance 
       Timeline  
Central Proteina Prima 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Central Proteina Prima has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, Central Proteina is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Bakrieland Development 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bakrieland Development Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Central Proteina and Bakrieland Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Central Proteina and Bakrieland Development

The main advantage of trading using opposite Central Proteina and Bakrieland Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Central Proteina position performs unexpectedly, Bakrieland Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bakrieland Development will offset losses from the drop in Bakrieland Development's long position.
The idea behind Central Proteina Prima and Bakrieland Development Tbk pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device